Volume 3, Issue 22 | December 6, 2023

Pathophysiology of Active and Latent Myofascial Trigger Points

We are seeking male volunteers for a research study on tension headache and muscle physiology.

You may be eligible if you:

• Male
• Have or do not have regular tension headaches
• Are generally healthy with no history of fibromyalgia, diabetes, or bleeding disorders
• Aged 18-59

ARROW Weight Loss Study

Research Volunteers needed for 1 year research study looking at your body’s response to dietary changes after completing free weight loss program.

The ROSIE Study

The purpose of this study is to understand how shift work impacts heart health in women. 
We are inviting women ages 18-40 who currently engage in shift work to complete two, in-person visits between 1-2 hours over approximately a 3-month period. 

Inclusion criteria:

• shift worker
• non-smoking
• not taking medications to treat high blood pressure or cholesterol
• no current use of hormonal contraceptives 

The Mini MED Study: Foods from the Mediterranean Diet and Health

This study plans to learn more about how consuming a diet with foods typical to a Mediterranean Diet such as whole grains, fruits and vegetables in a Western-style diet compares to eating a typical Western-style diet. This study will look at how diet affects overall health including risk factors for heart disease, gut health and inflammation as well as underlying mechanisms linking whole food to health. Findings from this study will potentially inform effective dietary recommendations and interventions, thereby reducing chronic disease in humans.

You may qualify if you:           

• are between 30 and 69 years old
• have a BMI between 25-37 kg/m2
• have high blood pressure or high cholesterol
• have stable medication use
• have a relatively low intake of Mediterranean diet-style foods
• haven’t changed your exercise patterns within the last 3 months
• do not smoke

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)

This study plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes. This medication has been effective in reducing cardiovascular disease and diabetic kidney disease in adults with type 2 diabetes. This study aims to look at how well the medication works in type 1 diabetes. We will perform a randomized study to assess the effects of 8 months of once weekly subcutaneous semaglutide vs. once weekly placebo injections.